| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Pasquale Paribello, Mirko Manchia, Massimo Zedda, Federica Pinna, Bernardo Carpiniell. Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature. Medicina (Kaunas, Lithuania). vol 57. issue 8. 2021-08-31. PMID:34441022. |
clozapine is the only antipsychotic approved for treatment-resistant schizophrenia. |
2021-08-31 |
2023-08-13 |
Not clear |
| Orwa Albitar, Sabariah Noor Harun, Siti Nor Aizah Ahmad, Siti Maisharah Sheikh Ghadz. A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine. Pharmaceutics. vol 13. issue 8. 2021-08-31. PMID:34452082. |
clozapine remains the drug of choice for resistant schizophrenia. |
2021-08-31 |
2023-08-13 |
Not clear |
| Hindol Mukherjee, Vladimir Sazhi. Predictors of functioning and clinical outcomes in inpatient with schizophrenia on clozapine augmented with antipsychotics. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2021-08-31. PMID:34464166. |
predictors of functioning and clinical outcomes in inpatient with schizophrenia on clozapine augmented with antipsychotics. |
2021-08-31 |
2023-08-13 |
Not clear |
| Hindol Mukherjee, Vladimir Sazhi. Predictors of functioning and clinical outcomes in inpatient with schizophrenia on clozapine augmented with antipsychotics. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2021-08-31. PMID:34464166. |
we aimed at exploring predictors of improvement in clinical and functional outcomes of patients on clozapine with chronic treatment-resistant schizophrenia admitted into rehabilitation wards. |
2021-08-31 |
2023-08-13 |
Not clear |
| Sho Fujimoto, Naoyasu Ueda, Naoya Nishimura, Atsushi Naito, Junki Hiura, Kouichi Mashiba, Ayane Ikai, Kousuke Marutsuka, Kentaro Mizun. Clozapine-induced antineutrophil cytoplasmic antibody-associated vasculitis: a case report. Modern rheumatology case reports. vol 4. issue 1. 2021-08-25. PMID:33086971. |
herein, we report a case of a 48-year-old japanese woman with schizophrenia who presented with fever, arthralgia, myalgia and skin rash after 2 years of clozapine treatment. |
2021-08-25 |
2023-08-13 |
Not clear |
| Brandi L Bellissima, Alisha Vara, Nuala Helsby, Fintan Garavan, Malcolm D Tingl. Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort. Psychiatry research. vol 299. 2021-08-25. PMID:33799127. |
clozapine is a uniquely effective antipsychotic indicated for treatment-resistant schizophrenia. |
2021-08-25 |
2023-08-13 |
Not clear |
| Shinichi Imazu, Takeo Hata, Katsunori Toyoda, Yoichiro Kubo, Shigeru Yamauchi, Shinya Kinoshita, Masami Nishihara, Ken Inada, Tetsufumi Kanazaw. Safety profile of clozapine: Analysis using national registry data in Japan. Journal of psychiatric research. vol 141. 2021-08-25. PMID:34192602. |
clozapine is the only effective antipsychotic drug used for the treatment of treatment-resistant schizophrenia. |
2021-08-25 |
2023-08-13 |
Not clear |
| Young Tak Jo, Sung Woo Joo, Soojin Ahn, Youngjae Choi, Jungsun Le. Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study. BJPsych open. vol 7. issue 5. 2021-08-21. PMID:34342261. |
use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study. |
2021-08-21 |
2023-08-13 |
Not clear |
| Young Tak Jo, Sung Woo Joo, Soojin Ahn, Youngjae Choi, Jungsun Le. Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study. BJPsych open. vol 7. issue 5. 2021-08-21. PMID:34342261. |
clozapine is generally considered as the treatment of choice for patients with treatment-resistant schizophrenia (trs). |
2021-08-21 |
2023-08-13 |
Not clear |
| Julie R Larsen, Camilla K Svensson, Louise Vedtofte, Mathilde Lund Jakobsen, Hans Søe Jespersen, Michelle I Jakobsen, Kamuran Koyuncu, Ole Schjerning, Jimmi Nielsen, Claus T Ekstrøm, Jens J Holst, Christoph U Correll, Tina Vilsbøll, Anders Fink-Jense. High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine. CNS spectrums. vol 24. issue 4. 2021-08-20. PMID:30596361. |
high prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine. |
2021-08-20 |
2023-08-13 |
Not clear |
| Giulia Tronchin, Genevieve McPhilemy, Mohamed Ahmed, Liam Kilmartin, Laura Costello, Natalie J Forde, Leila Nabulsi, Theophilus N Akudjedu, Laurena Holleran, Brian Hallahan, Dara M Cannon, Colm McDonal. White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study. Psychiatry research. vol 298. 2021-08-19. PMID:33556689. |
white matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: a longitudinal diffusion imaging study. |
2021-08-19 |
2023-08-13 |
Not clear |
| Giulia Tronchin, Genevieve McPhilemy, Mohamed Ahmed, Liam Kilmartin, Laura Costello, Natalie J Forde, Leila Nabulsi, Theophilus N Akudjedu, Laurena Holleran, Brian Hallahan, Dara M Cannon, Colm McDonal. White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study. Psychiatry research. vol 298. 2021-08-19. PMID:33556689. |
this study investigates changes on white matter microstructure and neural networks after 6 months of switching to clozapine in schizophrenia patients compared to controls, and whether any changes are related to clinical variables. |
2021-08-19 |
2023-08-13 |
Not clear |
| Giulia Tronchin, Genevieve McPhilemy, Mohamed Ahmed, Liam Kilmartin, Laura Costello, Natalie J Forde, Leila Nabulsi, Theophilus N Akudjedu, Laurena Holleran, Brian Hallahan, Dara M Cannon, Colm McDonal. White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study. Psychiatry research. vol 298. 2021-08-19. PMID:33556689. |
t1 and diffusion-weighted mri images were acquired at baseline before commencing clozapine and after 6 months of treatment for 22 patients with treatment-resistant schizophrenia and 23 controls. |
2021-08-19 |
2023-08-13 |
Not clear |
| Katsunori Toyoda, Takeo Hata, Shigeru Yamauchi, Shinya Kinoshita, Masami Nishihara, Kazuhisa Uchiyama, Ken Inada, Tetsufumi Kanazaw. A descriptive study of 10-year clozapine use from the nationwide database in Japan. Psychiatry research. vol 297. 2021-08-19. PMID:33567393. |
this survey was conducted to identify the actual usage of clozapine and changes required to increase the number of patients with schizophrenia who would benefit from clozapine. |
2021-08-19 |
2023-08-13 |
human |
| Tiffany Buckley, Christopher Kitchen, Gopal Vyas, Nathan A Siegfried, Eshetu Tefera, Shuo Chen, Bethany A DiPaula, Deanna L Kell. Comparison of Novel Immunoassay With Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) for Therapeutic Drug Monitoring of Clozapine. Therapeutic drug monitoring. vol 42. issue 5. 2021-08-18. PMID:32569062. |
clozapine is the most effective antipsychotic for treatment-resistant schizophrenia. |
2021-08-18 |
2023-08-13 |
Not clear |
| Mustafa Cicek, William V McCall, Zhixing Yao, Harold A Sackeim, Peter Rosenquist, Nagy A Yousse. Is There Evidence That Stimulus Parameters and Electrode Placement Affect the Cognitive Side Effects of Electroconvulsive Therapy in Patients With Schizophrenia and Schizoaffective Disorder?: A Systematic Review. The journal of ECT. vol 37. issue 2. 2021-08-18. PMID:33369995. |
seventy percent of patients with treatment-resistant schizophrenia do not respond to clozapine. |
2021-08-18 |
2023-08-13 |
Not clear |
| Eromona Whiskey, Alex Barnard, Ebenezer Oloyede, Olubanke Dzahini, David M Taylor, Sukhwinder S Shergil. An evaluation of the variation and underuse of clozapine in the United Kingdom. Acta psychiatrica Scandinavica. vol 143. issue 4. 2021-08-18. PMID:33501659. |
clozapine is the only licensed treatment for treatment refractory schizophrenia. |
2021-08-18 |
2023-08-13 |
Not clear |
| Elias Wagner, Tatiana Oviedo-Salcedo, Nicola Pelzer, Wolfgang Strube, Isabel Maurus, Stefan Gutwinski, Stefanie Schreiter, Phillip Kleymann, Carla-Lou Morgenroth, Cynthia Okhuijsen-Pfeifer, Jurjen J Luykx, Peter Falkai, Thomas Schneider-Axmann, Alkomiet Hasa. Effects of Smoking Status on Remission and Metabolic and Cognitive Outcomes in Schizophrenia Patients Treated with Clozapine. Pharmacopsychiatry. vol 53. issue 6. 2021-08-13. PMID:32757178. |
effects of smoking status on remission and metabolic and cognitive outcomes in schizophrenia patients treated with clozapine. |
2021-08-13 |
2023-08-13 |
Not clear |
| Xiding Yang, Qiangyong Yan, Lingfeng Yang, Jingjing Li, Xiao Fan, Jindong Chen, Haishan Wu, Hualin Cai, Ronghua Zhu, Pingfei Fan. Evaluation of bioequivalence between generic and brand-name clozapine in Chinese schizophrenic patients: A randomized, two-period, crossover study. International journal of clinical pharmacology and therapeutics. vol 59. issue 8. 2021-08-11. PMID:34142950. |
clozapine is the most effective therapy for schizophrenia. |
2021-08-11 |
2023-08-13 |
Not clear |
| Francesco Dal Santo, Isaac Jarratt-Barnham, Leticia González-Blanco, María Paz García-Portilla, Julio Bobes, Emilio Fernández-Ege. Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 33. 2021-08-10. PMID:32057590. |
previous cross-sectional studies have found clozapine to n-desmethylclozapine (clz:ndmc) ratio to be negatively correlated with cognition in clozapine-treated patients with schizophrenia. |
2021-08-10 |
2023-08-13 |
Not clear |